{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "X4cRE8IbIrIV"
   },
   "source": [
    "<div style=\"font-variant: small-caps; \n",
    "      font-weight: normal; \n",
    "      font-size: 35px; \n",
    "      text-align: center; \n",
    "      padding: 15px; \n",
    "      margin: 10px;\">\n",
    "      Tokenization\n",
    "  </div> \n",
    "  \n",
    "<div style=\"\n",
    "      font-weight: normal; \n",
    "      font-size: 25px; \n",
    "      text-align: center; \n",
    "      padding: 15px; \n",
    "      margin: 10px;\">\n",
    "      Unigram tokenizer - Clinical Trials CTTI\n",
    "  </div> \n",
    "\n",
    "\n",
    "  <div style=\" float:left; \n",
    "      font-size: 12px; \n",
    "      line-height: 12px; \n",
    "  padding: 10px 15px 8px;\">\n",
    "  Jean-baptiste AUJOGUE\n",
    "  </div> \n",
    "  \n",
    "  <div style=\" float:right; \n",
    "      font-size: 12px; \n",
    "      line-height: 12px; \n",
    "  padding: 10px 15px 8px;\">\n",
    "  December 2022\n",
    "  </div>"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a id=\"TOC\"></a>"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Table Of Content\n",
    "\n",
    "1. [Dataset](#data) <br>\n",
    "2. [ALBERT finetuning](#albert) <br>\n",
    "3. [Inference](#inference) <br>\n",
    "\n",
    "\n",
    "\n",
    "#### Reference\n",
    "\n",
    "- Hugginface full list of [tutorial notebooks](https://github.com/huggingface/transformers/tree/main/notebooks) (see also [here](https://huggingface.co/docs/transformers/main/notebooks#pytorch-examples))\n",
    "- Huggingface full list of [training scripts](https://github.com/huggingface/transformers/tree/main/examples/pytorch)\n",
    "- Huggingface [tutorial notebook](https://github.com/huggingface/notebooks/blob/main/examples/language_modeling_from_scratch.ipynb) on language models\n",
    "- Huggingface [course](https://huggingface.co/course/chapter7/3?fw=tf) on language models\n",
    "- Huggingface [training script](https://github.com/huggingface/transformers/blob/main/examples/pytorch/language-modeling/run_mlm.py) on language models\n",
    "- SentencePiece Unigram logic described in [Subword Regularization: Improving Neural Network Translation Models with Multiple Subword Candidates (2018)](https://arxiv.org/pdf/1804.10959.pdf)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "%load_ext autoreload\n",
    "%autoreload 2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\jb\\miniconda3\\envs\\transformers_nlp\\lib\\site-packages\\tqdm\\auto.py:22: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "import sys\n",
    "import re\n",
    "import random\n",
    "import copy\n",
    "import string\n",
    "import json\n",
    "from itertools import chain\n",
    "\n",
    "# data\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "from datasets import (\n",
    "    Dataset, \n",
    "    DatasetDict,\n",
    "    ClassLabel, \n",
    "    Features, \n",
    "    Sequence, \n",
    "    Value,\n",
    "    load_from_disk,\n",
    ")\n",
    "import transformers\n",
    "from transformers import AlbertConfig, AutoConfig, AutoTokenizer, AlbertTokenizerFast\n",
    "\n",
    "# tokenize\n",
    "from tokenizers import decoders, models, normalizers, pre_tokenizers, processors, trainers, Tokenizer"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Transformers settings"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'4.22.2'"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "transformers.__version__"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Custom paths & imports"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "path_to_repo = os.path.dirname(os.getcwd())\n",
    "path_to_data = os.path.join(path_to_repo, 'datasets')\n",
    "path_to_save = os.path.join(path_to_repo, 'saves', 'MLM')\n",
    "path_to_src  = os.path.join(path_to_repo, 'src')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "sys.path.insert(0, path_to_src)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Constants"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "dataset_name = 'clinical trials ICTRP/clinical-trials-ictrp'\n",
    "base_model_name = \"albert-base-v2\"\n",
    "final_model_name = \"albert-small-ictrp\""
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<a id=\"data\"></a>"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "whPRbBNbIrIl"
   },
   "source": [
    "# 1. Dataset\n",
    "\n",
    "[Table of content](#TOC)\n",
    "\n",
    "We generate a collection of instances of the `datasets.Dataset` class. \n",
    "\n",
    "Note that these are different from the fairly generic `torch.utils.data.Dataset` class. "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 1.1 Load Clinical Trials corpus\n",
    "\n",
    "[Table of content](#TOC)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "with open(os.path.join(path_to_data, '{}.txt'.format(dataset_name)), 'r', encoding = 'utf-8') as f:\n",
    "    texts = [t.strip() for t in f.readlines()]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "dataset = Dataset.from_dict({'text': texts}, features = Features({'text': Value(dtype = 'string')}))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1081670"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(dataset)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'text': [\"Capable of giving signed informed consent. Has received, been intolerant to, or been ineligible for all treatment options proven, to confer clinical benefit. Measurable disease per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1. Eastern Cooperative Oncology Group (ECOG) Performance status (PS) of 0 or 1. Adequate organ function. Male individuals and female individuals of childbearing potential who engage in, heterosexual intercourse must agree to use methods of contraception. Female participants are eligible if they are not pregnant, not breastfeeding or not a, Woman of childbearing potential (WOCBP). Inclusion criterion for the dose-escalation: Individuals with histologically or, cytologically confirmed, advanced or metastatic solid tumors. Inclusion criterion for disease-specific combination expansion: Individuals with, histologically or cytologically confirmed Triple-negative breast cancer (TNBC), Non-small cell lung cancer (NSCLC), Head and neck squamous cell carcinoma (HNSCC), or, melanoma. Inclusion criterion for the monotherapy-MoA expansion: Individuals with histologically, or cytologically confirmed NSCLC. Willingness and medical feasibility (as per Investigator assessment) to undergo paired, tumor biopsies with a non-significant risk. A known additional malignancy that is progressing or has required active treatment, within the past 3 years. Primary central nervous system malignancy. Major surgery = 28 days before start of study treatment. Any unresolved toxicity of Grade = 2, not otherwise specified in other eligibility, criteria, from previous anticancer treatment, except for alopecia and skin, pigmentation. Uncontrolled intercurrent illness requiring systemic treatment or solid organ, transplant. Known hypersensitivity to study treatment or any drugs similar in structure or class, including severe hypersensitivity (= Grade 3) to pembrolizumab and/or any of its, excipients. Any toxicity (Grade 3 or 4) related to prior immunotherapy leading to prior treatment, discontinuation. History of congestive heart failure New York Heart Association (NYHA) >II. Medical history of (non-infectious) pneumonitis/interstitial lung disease (ILD), drug-induced ILD, radiation pneumonitis which required steroid treatment, or any, evidence of clinically-active pneumonitis/ILD. HIV-infection with a history of Kaposi sarcoma and/or Multicentric Castleman Disease. Known psychiatric or substance abuse disorder that would interfere with the, participant's ability to cooperate with the requirements of the study. History or current evidence of any condition, therapy, laboratory abnormality, or, other circumstance that might confound the results of the study or interfere with the, participant's participation for the full duration of the study, such that it is not in, the best interest of the participant to participate, in the opinion of the treating, Investigator. Any other history, condition, therapy, or uncontrolled intercurrent illness which, could in the opinion of the Investigator affect compliance with study requirements. New brain metastases on screening brain MRI/CT; previously treated brain metastases, that are progressive at screening or leptomeningeal disease. Prior therapy with a C-C motif chemokine receptor 8 (CCR8) depleting antibody. Prior allogeneic tissue/solid organ transplant. Radiation therapy to the lung that is > 30 Gy within 6 months before the start of, study treatment. Diagnosis of immunodeficiency or current chronic systemic steroid therapy (in dosing, exceeding 10 mg daily of prednisone equivalent). Active autoimmune disease that has required systemic treatment in the past 2 years.\",\n",
       "  \"1. Patients with ischemic symptoms and/or evidence of myocardial ischemia, 2. Presence of = 50% restenosis after prior implantation of drug-eluting stents in native, coronary vessels. 3. Availability of an OCT-pullback of the target lesion, 4. Written informed consent by the patient for participation in the study. 5. Age = 18 years, 1. Cardiogenic shock, 2. Acute ST-elevation myocardial infarction within 48 hours from symptom onset. 3. Target lesion located in left main trunk or bypass graft. 4. Previous treatment of the target lesion due to restenosis. 5. Severe renal insufficiency (glomerular filtration rate = 30 ml/min), 6. Contraindications to any components of the investigational devices or dual, antiplatelet therapy, 7. Pregnancy (present, suspected or planned) or positive pregnancy test. 8. Previous enrollment in this trial or participation in any other study at the time of, enrollment. 9. Malignancies or other comorbid conditions with life expectancy less than 12 months or, that may result in protocol non-compliance. 10. Patient's inability to fully comply with the study protocol\",\n",
       "  'Bilateral age-related cataract for which phacoemulsification extraction and posterior, IOL implantation has planned, Age 50-90, Visual potential in both eyes of 20/30 or better as determined by investigators, estimation, Normal findings in medical history and physical examination unless the investigator, considers an abnormality to be clinically irrelevant, Preceding ocular surgery or trauma, Relevant other ophthalmic diseases (such as retinal degenerations, etc.), Uncontrolled systemic or ocular disease']}"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dataset[:3]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "YVx71GdAIrJH"
   },
   "source": [
    "## 1.2 Build tokenizer\n",
    "\n",
    "[Table of content](#TOC)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "def batch_iterator(dataset, batch_size = 512):\n",
    "    for i in range(0, len(dataset), batch_size):\n",
    "        yield dataset[i: i + batch_size]['text']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "base_tokenizer = AutoTokenizer.from_pretrained(base_model_name)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['<pad>', '<unk>', '[CLS]', '[SEP]', '[MASK]']"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "v2i = base_tokenizer.get_vocab()\n",
    "i2v = {i: v for v, i in v2i.items()}\n",
    "[i2v[i] for i in range(5)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "# issue with this ! yields badly formed vocabulary, with punctuations at middle of tokens\n",
    "# tokenizer = base_tokenizer.train_new_from_iterator(batch_iterator(dataset, batch_size = 512), vocab_size = 5000)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "# see the different pre-tokenizers at https://huggingface.co/docs/tokenizers/components#pretokenizers\n",
    "# see also https://colab.research.google.com/github/huggingface/notebooks/blob/master/examples/tokenizer_training.ipynb#scrollTo=RZvnUm2PZV0H\n",
    "\n",
    "custom_pre_tokenizer = pre_tokenizers.Sequence([\n",
    "    # base albert pre-tokenizer\n",
    "    pre_tokenizers.WhitespaceSplit(),\n",
    "    pre_tokenizers.Metaspace(replacement = \"▁\", add_prefix_space = True),\n",
    "    \n",
    "    # isolate special characters in order not to have them at the middle of a word\n",
    "    # this is put after Metaspace in order not to include extra spaces\n",
    "    pre_tokenizers.Digits(),\n",
    "    pre_tokenizers.Punctuation(behavior = \"isolated\"),\n",
    "])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "tokenizer = Tokenizer(models.Unigram())\n",
    "tokenizer.normalizer     = base_tokenizer.backend_tokenizer.normalizer\n",
    "tokenizer.pre_tokenizer  = custom_pre_tokenizer #base_tokenizer.backend_tokenizer.pre_tokenizer \n",
    "tokenizer.post_processor = base_tokenizer.backend_tokenizer.post_processor\n",
    "tokenizer.decoder        = base_tokenizer.backend_tokenizer.decoder"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "# vocab_size has really unexpected behavior,\n",
    "# see https://github.com/huggingface/tokenizers/issues/903\n",
    "trainer = trainers.UnigramTrainer(\n",
    "    vocab_size = 15000, \n",
    "    special_tokens = ['<pad>', '<unk>', '[CLS]', '[SEP]', '[MASK]'], # order should be the same as base_tokenizer !\n",
    "    unk_token = \"<unk>\",\n",
    ")\n",
    "tokenizer.train_from_iterator(batch_iterator(dataset, batch_size = 512), trainer = trainer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "tokenizer = AlbertTokenizerFast(tokenizer_object = tokenizer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "('C:\\\\Users\\\\jb\\\\Desktop\\\\NLP\\\\perso - Transformers for NLP\\\\saves\\\\MLM\\\\albert-small-ictrp\\\\tokenizer\\\\tokenizer_config.json',\n",
       " 'C:\\\\Users\\\\jb\\\\Desktop\\\\NLP\\\\perso - Transformers for NLP\\\\saves\\\\MLM\\\\albert-small-ictrp\\\\tokenizer\\\\special_tokens_map.json',\n",
       " 'C:\\\\Users\\\\jb\\\\Desktop\\\\NLP\\\\perso - Transformers for NLP\\\\saves\\\\MLM\\\\albert-small-ictrp\\\\tokenizer\\\\tokenizer.json')"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tokenizer.save_pretrained(os.path.join(path_to_save, final_model_name, 'tokenizer'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['<pad>', '<unk>', '[CLS]', '[SEP]', '[MASK]']"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "v2i = tokenizer.get_vocab()\n",
    "i2v = {i: v for v, i in v2i.items()}\n",
    "[i2v[i] for i in range(5)]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "YVx71GdAIrJH"
   },
   "source": [
    "## 1.3 Inspect tokenizer\n",
    "\n",
    "[Table of content](#TOC)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "tokenizer = AutoTokenizer.from_pretrained(os.path.join(path_to_save, final_model_name, 'tokenizer'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "15000"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(tokenizer.get_vocab())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<AxesSubplot: ylabel='Frequency'>"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "pd.DataFrame([len(t) for t in tokenizer.get_vocab()], columns = ['Length']).plot.hist(bins = 20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['a',\n",
       " '29',\n",
       " 'e',\n",
       " '64',\n",
       " 'μl',\n",
       " '69',\n",
       " '16',\n",
       " 'r',\n",
       " '”',\n",
       " '17',\n",
       " '00',\n",
       " '±',\n",
       " '88',\n",
       " '95',\n",
       " '~',\n",
       " 'l',\n",
       " 'y',\n",
       " '–',\n",
       " '‹',\n",
       " '§',\n",
       " 'ð',\n",
       " '@',\n",
       " 'd',\n",
       " 'ck',\n",
       " '(',\n",
       " ']',\n",
       " '80',\n",
       " 'in',\n",
       " 'c',\n",
       " 'be',\n",
       " 'o',\n",
       " '¿',\n",
       " '?',\n",
       " 'he',\n",
       " '×',\n",
       " 'μg',\n",
       " 'th',\n",
       " '°c',\n",
       " 'm',\n",
       " '55',\n",
       " '%',\n",
       " 'œ',\n",
       " '_',\n",
       " '27',\n",
       " 'þ',\n",
       " '89',\n",
       " '28',\n",
       " 'by',\n",
       " '1',\n",
       " '19',\n",
       " '25',\n",
       " '}',\n",
       " 'ß',\n",
       " '+',\n",
       " 'kg',\n",
       " '72',\n",
       " '50',\n",
       " 'b',\n",
       " ':',\n",
       " '96',\n",
       " '38',\n",
       " 'w',\n",
       " '=',\n",
       " ',',\n",
       " 'μ',\n",
       " '39',\n",
       " ';',\n",
       " 't',\n",
       " '2',\n",
       " 'i',\n",
       " 'j',\n",
       " 'ul',\n",
       " 'μm',\n",
       " '44',\n",
       " '6',\n",
       " 'f',\n",
       " '#',\n",
       " '-',\n",
       " 'us',\n",
       " 'ly',\n",
       " 'of',\n",
       " '▁',\n",
       " '24',\n",
       " '<',\n",
       " '°f',\n",
       " '—',\n",
       " 'h',\n",
       " 'x®',\n",
       " 'mm',\n",
       " '·',\n",
       " 'qu',\n",
       " 'z',\n",
       " '35',\n",
       " 'p',\n",
       " '8',\n",
       " '09',\n",
       " '>',\n",
       " '14',\n",
       " '48',\n",
       " '9',\n",
       " ')',\n",
       " '75',\n",
       " '’',\n",
       " '59',\n",
       " 'x',\n",
       " 'ju',\n",
       " 'up',\n",
       " \"'\",\n",
       " '12',\n",
       " '£',\n",
       " '\"',\n",
       " '&',\n",
       " '7',\n",
       " '`',\n",
       " '49',\n",
       " '13',\n",
       " '15',\n",
       " 'g',\n",
       " 'ø',\n",
       " 'u',\n",
       " '18',\n",
       " '{',\n",
       " '.',\n",
       " '73',\n",
       " '40',\n",
       " '90',\n",
       " '20',\n",
       " '79',\n",
       " '85',\n",
       " 'v',\n",
       " '60',\n",
       " '3',\n",
       " '30',\n",
       " 'iv',\n",
       " '/',\n",
       " '45',\n",
       " '†',\n",
       " '70',\n",
       " 'k',\n",
       " 'or',\n",
       " '®',\n",
       " '36',\n",
       " '*',\n",
       " '26',\n",
       " '^',\n",
       " '‘',\n",
       " 'q',\n",
       " '⁄',\n",
       " '[',\n",
       " '¬',\n",
       " '•',\n",
       " '99',\n",
       " '°',\n",
       " '4',\n",
       " '›',\n",
       " '5',\n",
       " '10',\n",
       " 's',\n",
       " '65',\n",
       " '0',\n",
       " '¡',\n",
       " '37',\n",
       " 'n']"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "[t for t in tokenizer.get_vocab() if len(t) <= 2]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'processing': 7930,\n",
       " 'sulfonylurea': 12040,\n",
       " '▁periodic': 3169,\n",
       " 'bal': 7395,\n",
       " 'confirmation': 10441,\n",
       " '▁multifeta': 12481,\n",
       " '▁tcm': 5697,\n",
       " '▁unaffected': 9196,\n",
       " 'rejuvenati': 13403,\n",
       " '▁cyp': 865,\n",
       " 'performed': 6133,\n",
       " 'ndan': 10142,\n",
       " 'observance': 14734,\n",
       " '▁yellow': 4798,\n",
       " 'intermediate': 9435,\n",
       " '▁expectoration': 12363,\n",
       " 'desvenlafaxin': 14170,\n",
       " 'ated': 1688,\n",
       " '▁spirits': 3841,\n",
       " '▁injection': 749,\n",
       " '▁patient': 77,\n",
       " 'years': 1883,\n",
       " '▁registere': 2595,\n",
       " '▁propranolol': 7817,\n",
       " 'benefit': 10535,\n",
       " 'myelitis': 6618,\n",
       " '▁engagement': 9093,\n",
       " 'terone': 12049,\n",
       " '▁ireland': 13843,\n",
       " 'prilocaine': 14062,\n",
       " '▁observ': 11614,\n",
       " '▁hcp': 11632,\n",
       " 'juan': 2956,\n",
       " '▁living': 1206,\n",
       " '▁confirmator': 3603,\n",
       " 'a': 14,\n",
       " 'aza': 4256,\n",
       " 'lymph': 5627,\n",
       " 'hpv': 8587,\n",
       " 'paired': 10194,\n",
       " 'trus': 7733,\n",
       " '▁with': 19,\n",
       " '▁natal': 3966,\n",
       " '▁matter': 5486,\n",
       " '▁hold': 6333,\n",
       " 'gravid': 6203,\n",
       " '▁urethroplast': 14972,\n",
       " '▁respiratoire': 14574,\n",
       " '▁ophthalmic': 2832,\n",
       " '▁thromboplastin': 2360,\n",
       " '▁macrosomi': 11869,\n",
       " 'lukast': 7494,\n",
       " '▁terminolog': 2715,\n",
       " '▁seven': 2990,\n",
       " '▁nemoliz': 14384,\n",
       " 'dehydrogenase': 14558,\n",
       " '▁typhoid': 8563,\n",
       " '▁preventive': 5599,\n",
       " '▁myorelaxant': 14989,\n",
       " 'brachial': 6371,\n",
       " '▁amino': 3588,\n",
       " 'follicular': 11478,\n",
       " '▁venous': 898,\n",
       " '▁exacerbation': 1217,\n",
       " '▁criterio': 8770,\n",
       " '▁encephalomyel': 12535,\n",
       " '▁restricte': 2856,\n",
       " 'tobacco': 9736,\n",
       " '▁ipss': 5496,\n",
       " 'radiology': 10736,\n",
       " 'important': 14642,\n",
       " '▁extrem': 14118,\n",
       " '▁vitamins': 2441,\n",
       " '▁steps': 7211,\n",
       " 'ville': 10336,\n",
       " 'chicken': 11253,\n",
       " 'straus': 9503,\n",
       " 'dalfampr': 14647,\n",
       " '▁tachyarrhythmia': 7108,\n",
       " '▁lenva': 7340,\n",
       " '▁jeopardise': 7699,\n",
       " '▁lumbo': 12771,\n",
       " 'definida': 8408,\n",
       " '▁opacities': 6117,\n",
       " '▁hyperglycemia': 4705,\n",
       " '▁sickness': 6235,\n",
       " 'cine': 8090,\n",
       " 'value': 8961,\n",
       " '▁sulphasalazin': 13095,\n",
       " '▁stavudin': 13312,\n",
       " 'provide': 8663,\n",
       " '▁aphasia': 3372,\n",
       " '▁hepatique': 11764,\n",
       " '▁bariatric': 2469,\n",
       " '▁nifedipin': 9776,\n",
       " '▁jelly': 5002,\n",
       " 'tech': 6676,\n",
       " 'shift': 10133,\n",
       " '▁submitted': 3883,\n",
       " '▁thrombin': 6793,\n",
       " 'strength': 13788,\n",
       " 'requisite': 11508,\n",
       " '▁investigador': 4548,\n",
       " '▁mandarin': 9652,\n",
       " 'petrosi': 13259,\n",
       " 'schizophrenia': 7775,\n",
       " '▁digital': 3938,\n",
       " '▁estimation': 5576,\n",
       " 'junction': 3569,\n",
       " '▁osseo': 8296,\n",
       " '▁unexpected': 7785,\n",
       " '▁judges': 4881,\n",
       " 'tropic': 6643,\n",
       " '▁examine': 5273,\n",
       " '▁arch': 5236,\n",
       " 'biliary': 7852,\n",
       " 'galactos': 13500,\n",
       " '▁piercing': 6836,\n",
       " 'pic': 4044,\n",
       " '▁justic': 6606,\n",
       " '▁cooperate': 1342,\n",
       " 'chro': 8398,\n",
       " 'interview': 13006,\n",
       " 'using': 2704,\n",
       " '▁serve': 5196,\n",
       " '▁unless': 491,\n",
       " '▁estudio': 1746,\n",
       " '▁bioavailab': 11313,\n",
       " '▁estimated': 887,\n",
       " 'spasm': 8489,\n",
       " '▁disabl': 5042,\n",
       " 'gonadal': 9078,\n",
       " '▁punctu': 10755,\n",
       " '▁spondylosis': 8101,\n",
       " 'emopoietic': 10967,\n",
       " 'nine': 5626,\n",
       " '▁void': 6440,\n",
       " 'ontium': 10821,\n",
       " '▁legal': 690,\n",
       " '2020': 3828,\n",
       " '▁comprise': 6211,\n",
       " '▁clofibrat': 14764,\n",
       " 'mol': 1928,\n",
       " '▁doubt': 5041,\n",
       " '▁cola': 6468,\n",
       " '▁federation': 7266,\n",
       " '▁alternat': 11242,\n",
       " '▁topic': 8356,\n",
       " 'logmar': 12927,\n",
       " 'dipropionat': 9149,\n",
       " '▁excision': 2869,\n",
       " '▁dropped': 12096,\n",
       " 'gvhd': 4391,\n",
       " '▁dmard': 4471,\n",
       " '▁surface': 745,\n",
       " '▁vesico': 12978,\n",
       " '▁appliances': 7351,\n",
       " '▁procedimiento': 7450,\n",
       " '▁fvc': 4601,\n",
       " 'older': 9943,\n",
       " 'proven': 3393,\n",
       " '▁transurethral': 7103,\n",
       " '▁thromboembolism': 3396,\n",
       " '29': 1705,\n",
       " '▁delineate': 14066,\n",
       " 'cryopreserve': 11068,\n",
       " '▁endemic': 7021,\n",
       " 'target': 3331,\n",
       " '▁detectable': 2410,\n",
       " '▁concent': 9451,\n",
       " '▁concert': 13078,\n",
       " '▁literate': 5082,\n",
       " '▁necrosis': 2569,\n",
       " 'ascites': 10747,\n",
       " 'glycaemia': 12955,\n",
       " 'hiv': 562,\n",
       " 'leukaemi': 14042,\n",
       " '▁effect': 1381,\n",
       " '▁arsenic': 9813,\n",
       " '▁astemizol': 7332,\n",
       " '▁anesthesia': 935,\n",
       " 'retinoic': 10655,\n",
       " 'pyelonephrit': 14920,\n",
       " 'uri': 6052,\n",
       " '▁classical': 5219,\n",
       " '▁multivitamin': 5228,\n",
       " '▁intrauterine': 742,\n",
       " 'cellulaire': 14073,\n",
       " '▁fungal': 1297,\n",
       " 'irbesartan': 14087,\n",
       " 'canada': 7155,\n",
       " '▁eustachi': 14459,\n",
       " 'diamond': 12542,\n",
       " 'natural': 10220,\n",
       " '▁receptor': 838,\n",
       " 'fenfluramin': 14057,\n",
       " '▁rectal': 1676,\n",
       " 'active': 1329,\n",
       " '▁mismatche': 8227,\n",
       " '▁uniform': 10770,\n",
       " 'xeloda': 14139,\n",
       " '▁otitis': 4923,\n",
       " '▁transplante': 5958,\n",
       " '▁nitrosourea': 6503,\n",
       " '▁intercourse': 1257,\n",
       " '▁abortifacient': 8537,\n",
       " '▁intermediate': 2291,\n",
       " 'deben': 5417,\n",
       " '▁intolerabilit': 7979,\n",
       " '▁custom': 10292,\n",
       " '▁pathogenic': 5348,\n",
       " '▁unintentional': 8340,\n",
       " 'cataract': 11843,\n",
       " '▁measurement': 1324,\n",
       " '▁cleft': 5355,\n",
       " '▁lobectomy': 5562,\n",
       " '▁consent': 78,\n",
       " '▁var': 10326,\n",
       " '▁dopamine': 3482,\n",
       " 'e': 22,\n",
       " '▁mel': 6244,\n",
       " 'aspartate': 2985,\n",
       " 'compensate': 9712,\n",
       " '▁assistance': 2476,\n",
       " '▁apex': 9726,\n",
       " 'impulsivit': 14285,\n",
       " '▁hachinski': 7812,\n",
       " '▁retraction': 10482,\n",
       " 'condoms': 2299,\n",
       " '▁council': 7366,\n",
       " '▁infantile': 8196,\n",
       " '▁wide': 3702,\n",
       " '▁iodinate': 5850,\n",
       " '▁esophagit': 6839,\n",
       " '▁mononucleo': 12971,\n",
       " '▁lymphatic': 5156,\n",
       " '▁panuveiti': 13147,\n",
       " '▁portocava': 13714,\n",
       " 'uptake': 10670,\n",
       " 'arthritis': 9725,\n",
       " '▁agonist': 2190,\n",
       " '▁burkho': 9268,\n",
       " '▁snellen': 5329,\n",
       " '▁inappropriate': 1084,\n",
       " '▁serotonin': 3257,\n",
       " '▁perforat': 6937,\n",
       " 'potent': 10226,\n",
       " '▁tbi': 3835,\n",
       " 'epidemiology': 14593,\n",
       " 'nancy': 11309,\n",
       " 'pegylated': 13085,\n",
       " '▁tinzaparin': 14926,\n",
       " '▁silicone': 6553,\n",
       " 'hscr': 9011,\n",
       " '▁cauda': 6221,\n",
       " '▁paradoxical': 11935,\n",
       " 'ostat': 7010,\n",
       " '▁chondrosarcoma': 11155,\n",
       " '▁malnourishe': 10327,\n",
       " 'leum': 12632,\n",
       " '▁celiba': 12461,\n",
       " 'anti': 1398,\n",
       " 'plasm': 8777,\n",
       " '64': 331,\n",
       " '▁publication': 11353,\n",
       " '▁phosphatase': 1076,\n",
       " '▁finasterid': 7059,\n",
       " '▁outlet': 5149,\n",
       " '▁pgtc': 13079,\n",
       " 'cardiography': 9314,\n",
       " '▁kcal': 11086,\n",
       " 'manifest': 13042,\n",
       " '▁ethic': 2606,\n",
       " '▁subject': 86,\n",
       " '▁neuroectoderm': 12529,\n",
       " '▁local': 334,\n",
       " '▁substance': 540,\n",
       " '▁benzodiazepine': 4281,\n",
       " '▁bicalutamid': 6026,\n",
       " '▁changed': 2980,\n",
       " '▁acutely': 7170,\n",
       " 'electromyography': 13182,\n",
       " 'emesis': 7769,\n",
       " 'structural': 10857,\n",
       " '▁aetiolog': 6287,\n",
       " 'ation': 1003,\n",
       " '▁chimeri': 5038,\n",
       " '▁bronchoscopic': 11345,\n",
       " 'guardian': 2542,\n",
       " '▁conservative': 3578,\n",
       " '▁vicinit': 12206,\n",
       " '▁poisoning': 7620,\n",
       " '▁mastoid': 12875,\n",
       " 'haematocrit': 11812,\n",
       " '▁posture': 8531,\n",
       " '▁oz': 3814,\n",
       " 'phosphate': 5289,\n",
       " 'stat': 5422,\n",
       " 'prime': 10722,\n",
       " '▁rectoscop': 14725,\n",
       " 'inemia': 8543,\n",
       " 'cyp': 2763,\n",
       " 'healthy': 3622,\n",
       " '▁lactation': 908,\n",
       " 'hama': 8709,\n",
       " 'secretion': 13305,\n",
       " 'neuroradiologist': 14381,\n",
       " '▁agonists': 2115,\n",
       " '▁prostanoid': 10070,\n",
       " '▁individuals': 621,\n",
       " '▁interventions': 2346,\n",
       " '▁cleare': 5762,\n",
       " 'molecular': 6009,\n",
       " '▁conduction': 1941,\n",
       " 'mers': 9675,\n",
       " '▁diagnosticado': 13083,\n",
       " '▁syringomyeli': 14253,\n",
       " '▁phencyclidine': 6491,\n",
       " 'prevention': 11428,\n",
       " 'reported': 1594,\n",
       " '▁decreas': 5544,\n",
       " 'exilat': 12351,\n",
       " '▁enthes': 11158,\n",
       " 'real': 8074,\n",
       " '▁ptc': 10010,\n",
       " 'methylglutaryl': 14565,\n",
       " '▁sequel': 12032,\n",
       " '▁vertical': 5819,\n",
       " '▁sensitivitie': 8424,\n",
       " 'pmbcl': 13274,\n",
       " '▁psilocyb': 13425,\n",
       " '▁embargo': 14719,\n",
       " '▁aches': 10759,\n",
       " '▁confirming': 4449,\n",
       " '▁tinea': 7731,\n",
       " 'ents': 9349,\n",
       " 'intensity': 5981,\n",
       " '▁offer': 8394,\n",
       " 'nhanes': 8361,\n",
       " 'mix': 7672,\n",
       " '▁bronchitis': 3732,\n",
       " '▁cannot': 536,\n",
       " '▁sciatic': 11723,\n",
       " '▁quiet': 11206,\n",
       " 'cardiac': 2222,\n",
       " '▁intend': 2334,\n",
       " 'octreoscan': 14043,\n",
       " 'ientra': 14149,\n",
       " '▁delegate': 8716,\n",
       " '▁diastolic': 719,\n",
       " 'mycin': 11362,\n",
       " '▁hypersensitive': 4928,\n",
       " 'extreme': 9448,\n",
       " '▁previamente': 10224,\n",
       " '▁bradycardi': 13173,\n",
       " '▁presence': 225,\n",
       " '▁metyrapon': 14567,\n",
       " 'marrow': 8897,\n",
       " '▁coumarin': 6239,\n",
       " 'employe': 11106,\n",
       " '▁difference': 3215,\n",
       " '▁lymphodepleti': 10571,\n",
       " 'sweet': 10124,\n",
       " '▁μm': 6225,\n",
       " '▁blockage': 8254,\n",
       " 'fluoropyrimidine': 4350,\n",
       " 'mesalazine': 10557,\n",
       " '▁noninvasive': 5781,\n",
       " 'signed': 1687,\n",
       " '▁femoropoplitea': 12692,\n",
       " '▁still': 1708,\n",
       " '▁antibody': 480,\n",
       " 'mps': 5433,\n",
       " 'μl': 974,\n",
       " '▁cronica': 7511,\n",
       " '▁exit': 6306,\n",
       " 'ime': 4688,\n",
       " '▁incurr': 11500,\n",
       " '69': 4346,\n",
       " 'circumstance': 14961,\n",
       " 'ical': 4037,\n",
       " 'brough': 11654,\n",
       " '▁triglyceride': 2121,\n",
       " 'debridement': 14555,\n",
       " 'idad': 4409,\n",
       " 'qol': 7424,\n",
       " 'zen': 8331,\n",
       " 'anaphylactic': 2197,\n",
       " '▁uteri': 6037,\n",
       " '▁funcional': 9785,\n",
       " '▁expertise': 12316,\n",
       " 'bodies': 4804,\n",
       " '▁girdle': 10965,\n",
       " '▁polyphenol': 13353,\n",
       " 'anterior': 8003,\n",
       " '▁known': 99,\n",
       " '▁become': 615,\n",
       " '▁uti': 4182,\n",
       " 'regulat': 6995,\n",
       " '▁ava': 7644,\n",
       " '▁ag': 3874,\n",
       " '▁foetal': 10295,\n",
       " 'available': 8924,\n",
       " 'accurate': 13701,\n",
       " '▁fluvastatin': 11084,\n",
       " '▁resolve': 7234,\n",
       " '▁observation': 2262,\n",
       " 'met': 2857,\n",
       " 'ipersensibilidad': 8754,\n",
       " '▁avm': 11220,\n",
       " '▁ciai': 11112,\n",
       " 'occupational': 14192,\n",
       " '▁redness': 7655,\n",
       " 'defining': 5543,\n",
       " '▁leflunomid': 3902,\n",
       " '▁ggt': 5843,\n",
       " '▁papillary': 4266,\n",
       " 'elapsed': 2294,\n",
       " 'host': 5274,\n",
       " '▁relat': 6249,\n",
       " 'step': 7929,\n",
       " 'cpap': 6207,\n",
       " 'definitive': 14168,\n",
       " '▁kps': 5436,\n",
       " '▁result': 461,\n",
       " 'maximum': 4908,\n",
       " '▁undergoes': 10395,\n",
       " '▁verapamil': 4436,\n",
       " '▁specializ': 12814,\n",
       " 'sterile': 9008,\n",
       " 'fluorodeoxy': 11756,\n",
       " '▁hormonotherap': 12448,\n",
       " '▁immunological': 2570,\n",
       " '▁therefor': 3140,\n",
       " '▁orlistat': 6658,\n",
       " '▁antineoplaston': 14616,\n",
       " '▁subtype': 2602,\n",
       " '▁objetivo': 14688,\n",
       " '▁plexus': 7696,\n",
       " '▁practise': 12835,\n",
       " 'scrotal': 12585,\n",
       " 'typical': 8322,\n",
       " '▁filter': 6067,\n",
       " 'corporation': 11898,\n",
       " 'stead': 12480,\n",
       " '▁hyperosmolar': 6497,\n",
       " '▁lean': 9324,\n",
       " '▁obvious': 2090,\n",
       " 'resting': 7303,\n",
       " 'hypercalcemi': 14032,\n",
       " '▁ipad': 12340,\n",
       " '▁pivotal': 11178,\n",
       " 'pcv': 8815,\n",
       " '▁wear': 1960,\n",
       " 'fertility': 3661,\n",
       " '▁institutions': 7209,\n",
       " '▁stiffness': 4523,\n",
       " '▁leave': 4624,\n",
       " 'terol': 4865,\n",
       " '▁fitbit': 13532,\n",
       " '▁tonsillitis': 10049,\n",
       " '▁carbamazepine': 2358,\n",
       " '▁segun': 5202,\n",
       " '▁divert': 12367,\n",
       " 'malleola': 14361,\n",
       " 'project': 13745,\n",
       " '▁sequestrant': 8804,\n",
       " '▁copies': 1995,\n",
       " '▁colposcop': 8341,\n",
       " '16': 353,\n",
       " 'presion': 7734,\n",
       " '▁car': 2800,\n",
       " '▁neurological': 410,\n",
       " '▁congestive': 516,\n",
       " '▁estar': 8110,\n",
       " 'moxibus': 12398,\n",
       " 'stein': 9201,\n",
       " 'bronchial': 9708,\n",
       " '▁pertinent': 3400,\n",
       " '▁expos': 11842,\n",
       " '▁maximal': 2998,\n",
       " 'occurr': 12366,\n",
       " 'carpal': 11859,\n",
       " '▁bas': 6257,\n",
       " '▁chrom': 6810,\n",
       " 'failed': 12158,\n",
       " 'tumor': 1815,\n",
       " '▁spinal': 711,\n",
       " 'cardiomyopathies': 11583,\n",
       " '▁quotient': 7401,\n",
       " 'lant': 6106,\n",
       " 'fibrate': 8661,\n",
       " 'nafld': 11269,\n",
       " 'r': 58,\n",
       " 'tomographic': 11201,\n",
       " '▁girl': 10054,\n",
       " '▁irrigation': 10602,\n",
       " 'nephritis': 4332,\n",
       " '▁nephrotoxic': 6660,\n",
       " 'schizophreni': 14995,\n",
       " 'brca': 9217,\n",
       " '858': 7527,\n",
       " '▁ranitidin': 11140,\n",
       " '▁rotational': 12131,\n",
       " '▁distort': 11628,\n",
       " '▁vegf': 4546,\n",
       " '▁flexor': 7701,\n",
       " 'icos': 6880,\n",
       " '▁spindle': 14243,\n",
       " '▁privacy': 4424,\n",
       " 'hbeag': 12051,\n",
       " '▁spermicides': 7320,\n",
       " 'degenerative': 11800,\n",
       " '▁circumstance': 4481,\n",
       " '▁error': 4912,\n",
       " 'way': 7920,\n",
       " '▁routine': 1082,\n",
       " 'ambi': 9752,\n",
       " 'soft': 9444,\n",
       " '▁responses': 4626,\n",
       " '▁haemodynamical': 9963,\n",
       " 'epidural': 11429,\n",
       " '▁impaired': 880,\n",
       " '▁ovarian': 1171,\n",
       " '▁cardiopulmonary': 1965,\n",
       " '▁mon': 7259,\n",
       " '▁vasoconstricti': 14386,\n",
       " '▁succinyl': 13730,\n",
       " '▁nursing': 582,\n",
       " '▁incapable': 2685,\n",
       " '▁centralize': 11053,\n",
       " 'aemia': 4580,\n",
       " '▁clopidogrel': 2195,\n",
       " 'emancipate': 12963,\n",
       " '▁proto': 9570,\n",
       " '▁governmental': 12262,\n",
       " 'erson': 8305,\n",
       " 'intermittent': 10765,\n",
       " 'transporter': 7196,\n",
       " 'ctc': 5076,\n",
       " 'sept': 9002,\n",
       " '▁converting': 5871,\n",
       " 'hypereosinophili': 11735,\n",
       " '▁quetiapin': 5840,\n",
       " '▁mas': 3581,\n",
       " '▁artefact': 14093,\n",
       " '▁tooth': 2039,\n",
       " '▁cervical': 559,\n",
       " '▁policy': 6395,\n",
       " '▁dominat': 14019,\n",
       " '▁uncooperative': 3865,\n",
       " 'full': 7162,\n",
       " '▁unconsciousness': 8141,\n",
       " '▁recruited': 2239,\n",
       " '▁protection': 2279,\n",
       " '▁vomiting': 1697,\n",
       " '▁denosumab': 4490,\n",
       " '▁kan': 9903,\n",
       " '▁foundation': 6625,\n",
       " 'ureter': 9643,\n",
       " '▁actinic': 7658,\n",
       " '▁prior': 34,\n",
       " '▁jeopardiz': 14919,\n",
       " '▁naturally': 5338,\n",
       " '▁physiologically': 3555,\n",
       " '▁mesh': 7317,\n",
       " '▁podra': 8827,\n",
       " '▁sequestration': 13774,\n",
       " 'edad': 10494,\n",
       " 'vasectomized': 7815,\n",
       " '”': 1915,\n",
       " '▁terminate': 5056,\n",
       " 'vita': 8000,\n",
       " '▁carried': 4170,\n",
       " 'deciliter': 8894,\n",
       " 'qtcf': 3092,\n",
       " '▁loose': 5861,\n",
       " '▁spectrometr': 13257,\n",
       " '▁begin': 3089,\n",
       " '▁methacholin': 6438,\n",
       " 'matic': 7440,\n",
       " '▁prevalenc': 10146,\n",
       " '▁entitle': 10763,\n",
       " '▁chagas': 12445,\n",
       " '▁genetic': 1327,\n",
       " 'volunteers': 8677,\n",
       " '▁provisions': 7925,\n",
       " '17': 424,\n",
       " 'designee': 9861,\n",
       " '00': 1812,\n",
       " 'recommend': 9359,\n",
       " '▁ileostom': 4952,\n",
       " '▁korea': 9081,\n",
       " '▁rehabilitation': 1626,\n",
       " '▁don': 3660,\n",
       " '▁stabilization': 5545,\n",
       " '▁imipenem': 12880,\n",
       " '392108': 13755,\n",
       " 'clear': 7710,\n",
       " '▁colour': 9016,\n",
       " '▁structure': 1800,\n",
       " '▁growth': 961,\n",
       " '▁manifest': 4398,\n",
       " '▁residenc': 10108,\n",
       " '▁boron': 7749,\n",
       " '▁leakage': 6050,\n",
       " 'range': 4491,\n",
       " 'aminosalicylate': 7257,\n",
       " '▁scapula': 12274,\n",
       " 'azepam': 8837,\n",
       " 'riterium': 13199,\n",
       " '▁option': 4142,\n",
       " '▁vertex': 7267,\n",
       " '▁glenohumeral': 9499,\n",
       " 'permitted': 597,\n",
       " '▁levosime': 12625,\n",
       " '▁nasolacrimal': 13376,\n",
       " 'guardians': 5900,\n",
       " '▁pandemic': 7183,\n",
       " '▁ipf': 4701,\n",
       " '▁fungoide': 9352,\n",
       " '▁antibacterial': 3817,\n",
       " '▁cytologically': 1129,\n",
       " '▁ethosux': 14796,\n",
       " 'withdrawal': 11282,\n",
       " '▁reinforcement': 14184,\n",
       " 'personal': 7556,\n",
       " '▁thermo': 9875,\n",
       " 'woncb': 12382,\n",
       " '▁environment': 4902,\n",
       " '▁pectus': 13324,\n",
       " '▁nicorandil': 12980,\n",
       " '▁biologic': 788,\n",
       " '▁fibric': 13917,\n",
       " 'ecrf': 10913,\n",
       " '▁jaundice': 3133,\n",
       " 'cemente': 10942,\n",
       " '▁activities': 1313,\n",
       " '▁application': 1722,\n",
       " '▁cytomegalovirus': 4913,\n",
       " '▁beijing': 12592,\n",
       " '▁person': 930,\n",
       " '±': 2433,\n",
       " '▁acute': 175,\n",
       " '88': 3086,\n",
       " '▁view': 3008,\n",
       " '▁nervos': 3756,\n",
       " '▁agrees': 1111,\n",
       " '▁discontinu': 5510,\n",
       " 'inject': 8422,\n",
       " 'brazil': 13056,\n",
       " 'appendix': 2234,\n",
       " 'identifie': 5370,\n",
       " '▁fragilit': 7677,\n",
       " 'ampanel': 12840,\n",
       " 'ltbi': 11038,\n",
       " '▁significant': 113,\n",
       " '▁spect': 6424,\n",
       " '▁multiplie': 11761,\n",
       " '▁custod': 8085,\n",
       " '▁hydatid': 14803,\n",
       " '▁flunarizin': 11789,\n",
       " '▁neuroendocrine': 3359,\n",
       " 'clobetasol': 14887,\n",
       " '▁know': 4130,\n",
       " '▁methyl': 3320,\n",
       " 'heart': 2545,\n",
       " '▁jak': 4621,\n",
       " '▁sulfite': 13391,\n",
       " 'qft': 8870,\n",
       " '▁anticoagulant': 1173,\n",
       " '95': 1581,\n",
       " 'glioblastoma': 13655,\n",
       " '▁celsius': 6571,\n",
       " '▁fatigue': 2256,\n",
       " 'synchrony': 14664,\n",
       " '110': 1501,\n",
       " 'trastuzumab': 11528,\n",
       " '▁medi': 5100,\n",
       " '▁real': 4143,\n",
       " '▁dcis': 6073,\n",
       " 'levonorgestrel': 6150,\n",
       " '▁cytoreducti': 9522,\n",
       " 'mdrd': 3391,\n",
       " 'bronchioliti': 14444,\n",
       " 'arm': 3967,\n",
       " 'crcl': 3236,\n",
       " '▁hypotension': 1437,\n",
       " '▁restasis': 12626,\n",
       " '▁advantage': 13944,\n",
       " '▁outcome': 1470,\n",
       " 'ematuria': 8568,\n",
       " 'lute': 7516,\n",
       " '▁endothelial': 4244,\n",
       " '▁subsequent': 1816,\n",
       " 'partum': 4529,\n",
       " '▁pseudomembranou': 12903,\n",
       " '▁prosthesis': 2731,\n",
       " '▁femoral': 2226,\n",
       " 'cockroft': 9209,\n",
       " '▁paradigm': 13666,\n",
       " 'oopherectom': 14146,\n",
       " '▁gave': 5621,\n",
       " 'drospirenon': 14457,\n",
       " 'contributor': 12527,\n",
       " 'triple': 11965,\n",
       " '▁precancero': 11625,\n",
       " '▁freckle': 14323,\n",
       " '▁estimate': 4511,\n",
       " '▁antirheumatic': 7992,\n",
       " '▁kerato': 7297,\n",
       " '▁south': 4744,\n",
       " 'tartrazin': 14902,\n",
       " '▁convincing': 13972,\n",
       " 'ski': 6398,\n",
       " '▁rejection': 3647,\n",
       " '▁embolic': 6089,\n",
       " '▁fluticason': 5394,\n",
       " '▁sensitize': 8862,\n",
       " '~': 1945,\n",
       " '▁catchment': 7093,\n",
       " '▁monogenic': 11518,\n",
       " 'regular': 5789,\n",
       " '▁clozapin': 4012,\n",
       " '▁apnea': 1809,\n",
       " '▁ctc': 4891,\n",
       " '▁lvef': 2217,\n",
       " 'fibrotest': 10350,\n",
       " '▁proficient': 7074,\n",
       " '▁author': 4433,\n",
       " '▁vasodilat': 14640,\n",
       " 'viagra': 11942,\n",
       " '▁amantadine': 7101,\n",
       " '▁midwife': 11139,\n",
       " 'electroconvulsiv': 4761,\n",
       " '▁vincristin': 5793,\n",
       " '▁iiia': 6855,\n",
       " 'pancreaticoduode': 11543,\n",
       " '▁dehiscence': 10372,\n",
       " '▁confound': 1022,\n",
       " 'distribution': 14812,\n",
       " '6162': 9551,\n",
       " '▁inferior': 3604,\n",
       " 'lawrence': 4306,\n",
       " '▁deflazacort': 14635,\n",
       " '▁contraindica': 13453,\n",
       " 'cardiogenic': 11472,\n",
       " 'gfr': 2200,\n",
       " 'enamel': 7753,\n",
       " 'measure': 12370,\n",
       " '▁cholestas': 7265,\n",
       " '▁carcinomas': 3804,\n",
       " '▁physi': 8892,\n",
       " 'l': 43,\n",
       " '▁citrate': 6515,\n",
       " 'fluoro': 7510,\n",
       " '▁intestinal': 1409,\n",
       " 'chondroplasia': 14397,\n",
       " '▁dbp': 3001,\n",
       " '▁spo': 4109,\n",
       " 'copies': 9978,\n",
       " '▁manteni': 13583,\n",
       " '▁metoprolol': 10604,\n",
       " '▁punto': 13695,\n",
       " 'supin': 9244,\n",
       " 'meld': 7806,\n",
       " 'preoperative': 8763,\n",
       " '▁brocco': 12811,\n",
       " '▁alt': 598,\n",
       " 'transfer': 11147,\n",
       " '▁fair': 10069,\n",
       " '▁intraperitoneal': 7732,\n",
       " 'prbc': 10190,\n",
       " '▁epigastric': 9539,\n",
       " '2017': 3307,\n",
       " '▁civil': 9026,\n",
       " '▁medicacion': 6525,\n",
       " '▁showe': 3211,\n",
       " '▁precedant': 11306,\n",
       " '▁cardiopath': 11463,\n",
       " 'quasi': 11215,\n",
       " 'international': 3452,\n",
       " '▁african': 4255,\n",
       " 'optimal': 11001,\n",
       " '▁dyne': 11971,\n",
       " 'lipoproteinemia': 12620,\n",
       " '▁inversion': 8987,\n",
       " 'globu': 13024,\n",
       " '▁chronological': 8268,\n",
       " '▁opiod': 14013,\n",
       " '▁triathlon': 14839,\n",
       " 'albu': 6195,\n",
       " '▁deformation': 9316,\n",
       " '▁acknowledge': 11314,\n",
       " 'hepato': 12509,\n",
       " '▁abus': 6674,\n",
       " '▁fluorouracil': 6626,\n",
       " '▁hemianopia': 14620,\n",
       " 'resection': 8808,\n",
       " 'chimiotherapie': 12910,\n",
       " '▁ambulate': 6741,\n",
       " 'amenorrhoe': 14247,\n",
       " '▁maternit': 8740,\n",
       " '▁snake': 13856,\n",
       " '▁auriculo': 14395,\n",
       " '▁polyps': 2671,\n",
       " 'orthopaedic': 14699,\n",
       " 'galactose': 4367,\n",
       " '▁cellular': 4877,\n",
       " '▁peristo': 11626,\n",
       " '▁instruction': 6694,\n",
       " '▁nitrogen': 4768,\n",
       " '▁subarachnoid': 4057,\n",
       " '▁spring': 12628,\n",
       " '▁spine': 1415,\n",
       " '▁hospitalise': 6894,\n",
       " '▁switche': 5157,\n",
       " '▁pulpitis': 8203,\n",
       " 'thoraco': 8383,\n",
       " 'piece': 8385,\n",
       " 'relevant': 8670,\n",
       " '▁calibr': 11622,\n",
       " '▁planned': 408,\n",
       " 'indication': 2502,\n",
       " '▁split': 8712,\n",
       " '▁fviii': 3530,\n",
       " 'emetic': 8643,\n",
       " '▁inconsistent': 9269,\n",
       " '▁planus': 7957,\n",
       " '▁xanth': 10605,\n",
       " 'dilation': 11210,\n",
       " '▁secondary': 613,\n",
       " 'splenectomi': 13941,\n",
       " '▁dacarbazin': 9671,\n",
       " 'atum': 11291,\n",
       " '▁nephrolithias': 7484,\n",
       " '▁tele': 7237,\n",
       " 'ear': 1756,\n",
       " 'rituximab': 9431,\n",
       " '▁narcissis': 14541,\n",
       " '▁according': 251,\n",
       " '▁mucosal': 2858,\n",
       " '▁diverticulit': 3877,\n",
       " '▁binocular': 9375,\n",
       " '▁metal': 1255,\n",
       " '▁octreotide': 6653,\n",
       " '▁mielo': 13831,\n",
       " 'quan': 9990,\n",
       " 'derivate': 14429,\n",
       " 'calculator': 9419,\n",
       " '▁latter': 8576,\n",
       " 'y': 70,\n",
       " '▁systolic': 709,\n",
       " '▁cranial': 3323,\n",
       " '▁premorbid': 8913,\n",
       " '▁bone': 294,\n",
       " '▁vertebroplast': 12908,\n",
       " '▁bms': 5716,\n",
       " '▁valgus': 7025,\n",
       " '▁axi': 10050,\n",
       " '▁antidepressant': 1927,\n",
       " 'overexpress': 8867,\n",
       " 'pain': 4114,\n",
       " 'vata': 9493,\n",
       " 'arizona': 14123,\n",
       " '▁pharynx': 9924,\n",
       " 'complex': 11471,\n",
       " '▁high': 355,\n",
       " '▁myxoma': 11686,\n",
       " '▁edema': 1387,\n",
       " '▁stopping': 3528,\n",
       " 'palpable': 11099,\n",
       " '▁radiotracer': 13959,\n",
       " '▁fundoscop': 10702,\n",
       " '▁website': 9642,\n",
       " 'anastomotic': 9804,\n",
       " '▁abdomino': 10501,\n",
       " 'google': 14174,\n",
       " '▁plus': 1073,\n",
       " '▁fulminant': 6599,\n",
       " '▁consort': 11143,\n",
       " '▁mayor': 7094,\n",
       " '▁intramedulla': 12680,\n",
       " '▁purulent': 5343,\n",
       " 'disciplinary': 10473,\n",
       " 'she': 2199,\n",
       " 'diafragma': 13445,\n",
       " '▁block': 729,\n",
       " '▁pimavanser': 14761,\n",
       " '▁discourage': 12384,\n",
       " '▁hyperactivit': 5907,\n",
       " '▁conjunctival': 5901,\n",
       " '▁sites': 1309,\n",
       " '▁appropriate': 596,\n",
       " 'cirs': 11476,\n",
       " '▁counseling': 4974,\n",
       " 'approximate': 8093,\n",
       " 'histo': 6093,\n",
       " '▁iief': 11642,\n",
       " '▁rang': 4673,\n",
       " '–': 1118,\n",
       " '▁biochemistry': 3868,\n",
       " 'rating': 6248,\n",
       " 'ance': 2695,\n",
       " '▁shanghai': 11258,\n",
       " 'atteinte': 14806,\n",
       " '▁ergotamine': 8329,\n",
       " '▁rescreen': 9441,\n",
       " 'resistance': 9611,\n",
       " '▁ineffective': 6189,\n",
       " '▁cross': 3485,\n",
       " '▁slides': 3228,\n",
       " 'hysterectomize': 9670,\n",
       " '▁expectorate': 12709,\n",
       " 'glutamic': 12271,\n",
       " '▁levels': 571,\n",
       " '▁sulfonylurea': 4588,\n",
       " '▁several': 4584,\n",
       " '▁contract': 5018,\n",
       " '▁endocrinopathie': 9917,\n",
       " '▁accrual': 9124,\n",
       " '▁elderly': 340,\n",
       " '▁camera': 10412,\n",
       " 'thyroxine': 13739,\n",
       " 'condicion': 11110,\n",
       " '▁fit': 2399,\n",
       " '▁megaloblast': 14287,\n",
       " '▁music': 9420,\n",
       " '▁maneuver': 7704,\n",
       " '▁viral': 765,\n",
       " 'peritoneu': 9147,\n",
       " 'boostrix': 14924,\n",
       " '▁haemophilia': 5651,\n",
       " '▁tissue': 528,\n",
       " '▁harvest': 6876,\n",
       " 'ending': 2941,\n",
       " '▁gram': 2920,\n",
       " '▁erythema': 3345,\n",
       " 'rated': 5401,\n",
       " '▁infiltrate': 6004,\n",
       " 'defecat': 12926,\n",
       " 'coming': 9406,\n",
       " 'protection': 11384,\n",
       " '▁drinkers': 8826,\n",
       " '▁tube': 1506,\n",
       " 'intranasal': 11887,\n",
       " 'allergen': 11841,\n",
       " 'risperidone': 14522,\n",
       " 'fluorescence': 4422,\n",
       " 'maintenance': 8486,\n",
       " '▁testosterone': 2205,\n",
       " '▁prevista': 13916,\n",
       " '▁hydrogel': 11048,\n",
       " '▁antiviral': 1595,\n",
       " 'delete': 10172,\n",
       " '▁bio': 2716,\n",
       " '▁aliskiren': 10040,\n",
       " 'graviditet': 14436,\n",
       " '▁status': 203,\n",
       " '▁bipolar': 1012,\n",
       " 'nexavar': 14122,\n",
       " '▁tipran': 11180,\n",
       " 'mate': 6007,\n",
       " '▁data': 681,\n",
       " '▁toxoid': 8480,\n",
       " '▁additive': 13205,\n",
       " '▁neurotoxin': 12378,\n",
       " '▁patients': 31,\n",
       " 'gingival': 10887,\n",
       " 'macroalbuminur': 12027,\n",
       " 'genous': 7233,\n",
       " '▁exceede': 7839,\n",
       " 'graduate': 8128,\n",
       " 'methoxy': 12602,\n",
       " 'aldosteronism': 7807,\n",
       " 'chondroitin': 10321,\n",
       " 'mallampat': 12310,\n",
       " 'brenne': 14071,\n",
       " 'ted': 2169,\n",
       " '▁coombs': 11698,\n",
       " '▁tamoxifen': 3166,\n",
       " '▁neede': 1835,\n",
       " '▁wheat': 8539,\n",
       " 'hypopnoea': 14691,\n",
       " '▁sofa': 10077,\n",
       " 'immunoconjugate': 11332,\n",
       " 'ough': 11263,\n",
       " '▁penicillin': 4633,\n",
       " 'deplet': 6533,\n",
       " 'also': 6292,\n",
       " '▁five': 1212,\n",
       " '▁thyroxine': 4427,\n",
       " 'secreta': 13106,\n",
       " '▁atrioventricula': 2844,\n",
       " 'atory': 5740,\n",
       " '▁proposal': 13665,\n",
       " 'elevated': 7260,\n",
       " '▁polyangi': 7982,\n",
       " '▁french': 2015,\n",
       " '▁tired': 12696,\n",
       " ...}"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tokenizer.get_vocab()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(\"Capable of giving signed informed consent. Has received, been intolerant to, or been ineligible for all treatment options proven, to confer clinical benefit. Measurable disease per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1. Eastern Cooperative Oncology Group (ECOG) Performance status (PS) of 0 or 1. Adequate organ function. Male individuals and female individuals of childbearing potential who engage in, heterosexual intercourse must agree to use methods of contraception. Female participants are eligible if they are not pregnant, not breastfeeding or not a, Woman of childbearing potential (WOCBP). Inclusion criterion for the dose-escalation: Individuals with histologically or, cytologically confirmed, advanced or metastatic solid tumors. Inclusion criterion for disease-specific combination expansion: Individuals with, histologically or cytologically confirmed Triple-negative breast cancer (TNBC), Non-small cell lung cancer (NSCLC), Head and neck squamous cell carcinoma (HNSCC), or, melanoma. Inclusion criterion for the monotherapy-MoA expansion: Individuals with histologically, or cytologically confirmed NSCLC. Willingness and medical feasibility (as per Investigator assessment) to undergo paired, tumor biopsies with a non-significant risk. A known additional malignancy that is progressing or has required active treatment, within the past 3 years. Primary central nervous system malignancy. Major surgery = 28 days before start of study treatment. Any unresolved toxicity of Grade = 2, not otherwise specified in other eligibility, criteria, from previous anticancer treatment, except for alopecia and skin, pigmentation. Uncontrolled intercurrent illness requiring systemic treatment or solid organ, transplant. Known hypersensitivity to study treatment or any drugs similar in structure or class, including severe hypersensitivity (= Grade 3) to pembrolizumab and/or any of its, excipients. Any toxicity (Grade 3 or 4) related to prior immunotherapy leading to prior treatment, discontinuation. History of congestive heart failure New York Heart Association (NYHA) >II. Medical history of (non-infectious) pneumonitis/interstitial lung disease (ILD), drug-induced ILD, radiation pneumonitis which required steroid treatment, or any, evidence of clinically-active pneumonitis/ILD. HIV-infection with a history of Kaposi sarcoma and/or Multicentric Castleman Disease. Known psychiatric or substance abuse disorder that would interfere with the, participant's ability to cooperate with the requirements of the study. History or current evidence of any condition, therapy, laboratory abnormality, or, other circumstance that might confound the results of the study or interfere with the, participant's participation for the full duration of the study, such that it is not in, the best interest of the participant to participate, in the opinion of the treating, Investigator. Any other history, condition, therapy, or uncontrolled intercurrent illness which, could in the opinion of the Investigator affect compliance with study requirements. New brain metastases on screening brain MRI/CT; previously treated brain metastases, that are progressive at screening or leptomeningeal disease. Prior therapy with a C-C motif chemokine receptor 8 (CCR8) depleting antibody. Prior allogeneic tissue/solid organ transplant. Radiation therapy to the lung that is > 30 Gy within 6 months before the start of, study treatment. Diagnosis of immunodeficiency or current chronic systemic steroid therapy (in dosing, exceeding 10 mg daily of prednisone equivalent). Active autoimmune disease that has required systemic treatment in the past 2 years.\",\n",
       " \"[CLS] capable of giving signed informed consent. has received, been intolerant to, or been ineligible for all treatment options proven, to confer clinical benefit. measurable disease per response evaluation criteria in solid tumors (recist) 1.1. eastern cooperative oncology group (ecog) performance status (ps) of 0 or 1. adequate organ function. male individuals and female individuals of childbearing potential who engage in, heterosexual intercourse must agree to use methods of contraception. female participants are eligible if they are not pregnant, not breastfeeding or not a, woman of childbearing potential (wocbp). inclusion criterion for the dose-escalation: individuals with histologically or, cytologically confirmed, advanced or metastatic solid tumors. inclusion criterion for disease-specific combination expansion: individuals with, histologically or cytologically confirmed triple-negative breast cancer (tnbc), non-small cell lung cancer (nsclc), head and neck squamous cell carcinoma (hnscc), or, melanoma. inclusion criterion for the monotherapy-moa expansion: individuals with histologically, or cytologically confirmed nsclc. willingness and medical feasibility (as per investigator assessment) to undergo paired, tumor biopsies with a non-significant risk. a known additional malignancy that is progressing or has required active treatment, within the past 3 years. primary central nervous system malignancy. major surgery = 28 days before start of study treatment. any unresolved toxicity of grade = 2, not otherwise specified in other eligibility, criteria, from previous anticancer treatment, except for alopecia and skin, pigmentation. uncontrolled intercurrent illness requiring systemic treatment or solid organ, transplant. known hypersensitivity to study treatment or any drugs similar in structure or class, including severe hypersensitivity (= grade 3) to pembrolizumab and/or any of its, excipients. any toxicity (grade 3 or 4) related to prior immunotherapy leading to prior treatment, discontinuation. history of congestive heart failure new york heart association (nyha) >ii. medical history of (non-infectious) pneumonitis/interstitial lung disease (ild), drug-induced ild, radiation pneumonitis which required steroid treatment, or any, evidence of clinically-active pneumonitis/ild. hiv-infection with a history of kaposi sarcoma and/or multicentric castleman disease. known psychiatric or substance abuse disorder that would interfere with the, participant's ability to cooperate with the requirements of the study. history or current evidence of any condition, therapy, laboratory abnormality, or, other circumstance that might confound the results of the study or interfere with the, participant's participation for the full duration of the study, such that it is not in, the best interest of the participant to participate, in the opinion of the treating, investigator. any other history, condition, therapy, or uncontrolled intercurrent illness which, could in the opinion of the investigator affect compliance with study requirements. new brain metastases on screening brain mri/ct; previously treated brain metastases, that are progressive at screening or leptomeningeal disease. prior therapy with a c-c motif chemokine receptor 8 (ccr8) depleting antibody. prior allogeneic tissue/solid organ transplant. radiation therapy to the lung that is > 30 gy within 6 months before the start of, study treatment. diagnosis of immunodeficiency or current chronic systemic steroid therapy (in dosing, exceeding 10 mg daily of prednisone equivalent). active autoimmune disease that has required systemic treatment in the past 2 years.[SEP]\")"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "texts[0], tokenizer.decode(tokenizer(texts[0])['input_ids'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('▁capable', 857),\n",
       " ('▁of', 8),\n",
       " ('▁giving', 1377),\n",
       " ('▁signed', 343),\n",
       " ('▁informed', 90),\n",
       " ('▁consent', 78),\n",
       " ('.', 7),\n",
       " ('▁has', 72),\n",
       " ('▁received', 166),\n",
       " (',', 6),\n",
       " ('▁been', 172),\n",
       " ('▁intolerant', 2225),\n",
       " ('▁to', 13),\n",
       " (',', 6),\n",
       " ('▁or', 10),\n",
       " ('▁been', 172),\n",
       " ('▁ineligible', 1311),\n",
       " ('▁for', 20),\n",
       " ('▁all', 159),\n",
       " ('▁treatment', 56),\n",
       " ('▁options', 3610),\n",
       " ('▁proven', 1085),\n",
       " (',', 6),\n",
       " ('▁to', 13),\n",
       " ('▁confer', 8934),\n",
       " ('▁clinical', 103),\n",
       " ('▁benefit', 1432),\n",
       " ('.', 7),\n",
       " ('▁measurable', 483),\n",
       " ('▁disease', 42),\n",
       " ('▁per', 196),\n",
       " ('▁response', 515),\n",
       " ('▁evaluation', 473),\n",
       " ('▁criteria', 96),\n",
       " ('▁in', 21),\n",
       " ('▁solid', 881),\n",
       " ('▁tumors', 586),\n",
       " ('▁', 5),\n",
       " ('(', 12),\n",
       " ('recist', 2191),\n",
       " (')', 11),\n",
       " ('▁', 5),\n",
       " ('1', 18),\n",
       " ('.', 7),\n",
       " ('1', 18),\n",
       " ('.', 7),\n",
       " ('▁eastern', 826),\n",
       " ('▁cooperative', 734),\n",
       " ('▁oncology', 702),\n",
       " ('▁group', 337),\n",
       " ('▁', 5),\n",
       " ('(', 12),\n",
       " ('ecog', 682),\n",
       " (')', 11),\n",
       " ('▁performance', 335),\n",
       " ('▁status', 203),\n",
       " ('▁', 5),\n",
       " ('(', 12),\n",
       " ('p', 84),\n",
       " ('s', 15),\n",
       " (')', 11),\n",
       " ('▁of', 8),\n",
       " ('▁', 5),\n",
       " ('0', 92),\n",
       " ('▁or', 10),\n",
       " ('▁', 5),\n",
       " ('1', 18),\n",
       " ('.', 7),\n",
       " ('▁adequate', 261),\n",
       " ('▁organ', 423),\n",
       " ('▁function', 176),\n",
       " ('.', 7),\n",
       " ('▁male', 189),\n",
       " ('▁individuals', 621),\n",
       " ('▁and', 17),\n",
       " ('▁female', 137),\n",
       " ('▁individuals', 621),\n",
       " ('▁of', 8),\n",
       " ('▁childbearing', 242),\n",
       " ('▁potential', 139),\n",
       " ('▁who', 54),\n",
       " ('▁engage', 2721),\n",
       " ('▁in', 21),\n",
       " (',', 6),\n",
       " ('▁heterosexual', 1784),\n",
       " ('▁intercourse', 1257),\n",
       " ('▁must', 69),\n",
       " ('▁agree', 309),\n",
       " ('▁to', 13),\n",
       " ('▁use', 82),\n",
       " ('▁methods', 402),\n",
       " ('▁of', 8),\n",
       " ('▁contraception', 188),\n",
       " ('.', 7),\n",
       " ('▁female', 137),\n",
       " ('▁participants', 209),\n",
       " ('▁are', 59),\n",
       " ('▁eligible', 222),\n",
       " ('▁', 5),\n",
       " ('i', 27),\n",
       " ('f', 39),\n",
       " ('▁they', 348),\n",
       " ('▁are', 59),\n",
       " ('▁not', 60),\n",
       " ('▁pregnant', 123),\n",
       " (',', 6),\n",
       " ('▁not', 60),\n",
       " ('▁breastfeeding', 482),\n",
       " ('▁or', 10),\n",
       " ('▁not', 60),\n",
       " ('▁', 5),\n",
       " ('a', 14),\n",
       " (',', 6),\n",
       " ('▁woman', 738),\n",
       " ('▁of', 8),\n",
       " ('▁childbearing', 242),\n",
       " ('▁potential', 139),\n",
       " ('▁', 5),\n",
       " ('(', 12),\n",
       " ('wocbp', 1961),\n",
       " (')', 11),\n",
       " ('.', 7),\n",
       " ('▁inclusion', 215),\n",
       " ('▁criterion', 966),\n",
       " ('▁for', 20),\n",
       " ('▁the', 9),\n",
       " ('▁dose', 118),\n",
       " ('-', 16),\n",
       " ('escalation', 10937),\n",
       " (':', 38),\n",
       " ('▁individuals', 621),\n",
       " ('▁with', 19),\n",
       " ('▁histologically', 531),\n",
       " ('▁or', 10),\n",
       " (',', 6),\n",
       " ('▁cytologically', 1129),\n",
       " ('▁confirmed', 213),\n",
       " (',', 6),\n",
       " ('▁advanced', 524),\n",
       " ('▁or', 10),\n",
       " ('▁metastatic', 399),\n",
       " ('▁solid', 881),\n",
       " ('▁tumors', 586),\n",
       " ('.', 7),\n",
       " ('▁inclusion', 215),\n",
       " ('▁criterion', 966),\n",
       " ('▁for', 20),\n",
       " ('▁disease', 42),\n",
       " ('-', 16),\n",
       " ('specific', 1049),\n",
       " ('▁combination', 737),\n",
       " ('▁expansion', 3269),\n",
       " (':', 38),\n",
       " ('▁individuals', 621),\n",
       " ('▁with', 19),\n",
       " (',', 6),\n",
       " ('▁histologically', 531),\n",
       " ('▁or', 10),\n",
       " ('▁cytologically', 1129),\n",
       " ('▁confirmed', 213),\n",
       " ('▁triple', 3825),\n",
       " ('-', 16),\n",
       " ('negative', 1761),\n",
       " ('▁breast', 249),\n",
       " ('▁cancer', 114),\n",
       " ('▁', 5),\n",
       " ('(', 12),\n",
       " ('tnbc', 11975),\n",
       " (')', 11),\n",
       " (',', 6),\n",
       " ('▁non', 122),\n",
       " ('-', 16),\n",
       " ('small', 1998),\n",
       " ('▁cell', 177),\n",
       " ('▁lung', 380),\n",
       " ('▁cancer', 114),\n",
       " ('▁', 5),\n",
       " ('(', 12),\n",
       " ('nsclc', 4487),\n",
       " (')', 11),\n",
       " (',', 6),\n",
       " ('▁head', 764),\n",
       " ('▁and', 17),\n",
       " ('▁neck', 900),\n",
       " ('▁squamous', 601),\n",
       " ('▁cell', 177),\n",
       " ('▁carcinoma', 224),\n",
       " ('▁', 5),\n",
       " ('(', 12),\n",
       " ('hnscc', 12998),\n",
       " (')', 11),\n",
       " (',', 6),\n",
       " ('▁or', 10),\n",
       " (',', 6),\n",
       " ('▁melanoma', 1335),\n",
       " ('.', 7),\n",
       " ('▁inclusion', 215),\n",
       " ('▁criterion', 966),\n",
       " ('▁for', 20),\n",
       " ('▁the', 9),\n",
       " ('▁monotherapy', 2168),\n",
       " ('-', 16),\n",
       " ('m', 66),\n",
       " ('o', 30),\n",
       " ('a', 14),\n",
       " ('▁expansion', 3269),\n",
       " (':', 38),\n",
       " ('▁individuals', 621),\n",
       " ('▁with', 19),\n",
       " ('▁histologically', 531),\n",
       " (',', 6),\n",
       " ('▁or', 10),\n",
       " ('▁cytologically', 1129),\n",
       " ('▁confirmed', 213),\n",
       " ('▁nsclc', 1226),\n",
       " ('.', 7),\n",
       " ('▁willingness', 691),\n",
       " ('▁and', 17),\n",
       " ('▁medical', 112),\n",
       " ('▁', 5),\n",
       " ('f', 39),\n",
       " ('e', 22),\n",
       " ('a', 14),\n",
       " ('s', 15),\n",
       " ('ibility', 7207),\n",
       " ('▁', 5),\n",
       " ('(', 12),\n",
       " ('a', 14),\n",
       " ('s', 15),\n",
       " ('▁per', 196),\n",
       " ('▁investigator', 106),\n",
       " ('▁assessment', 451),\n",
       " (')', 11),\n",
       " ('▁to', 13),\n",
       " ('▁undergo', 588),\n",
       " ('▁', 5),\n",
       " ('paired', 10194),\n",
       " (',', 6),\n",
       " ('▁tumor', 256),\n",
       " ('▁biopsie', 2005),\n",
       " ('s', 15),\n",
       " ('▁with', 19),\n",
       " ('▁', 5),\n",
       " ('a', 14),\n",
       " ('▁non', 122),\n",
       " ('-', 16),\n",
       " ('significant', 2456),\n",
       " ('▁risk', 182),\n",
       " ('.', 7),\n",
       " ('▁', 5),\n",
       " ('a', 14),\n",
       " ('▁known', 99),\n",
       " ('▁additional', 678),\n",
       " ('▁malignancy', 271),\n",
       " ('▁that', 67),\n",
       " ('▁is', 53),\n",
       " ('▁progress', 2164),\n",
       " ('ing', 88),\n",
       " ('▁or', 10),\n",
       " ('▁has', 72),\n",
       " ('▁required', 306),\n",
       " ('▁active', 100),\n",
       " ('▁treatment', 56),\n",
       " (',', 6),\n",
       " ('▁within', 41),\n",
       " ('▁the', 9),\n",
       " ('▁past', 161),\n",
       " ('▁', 5),\n",
       " ('3', 28),\n",
       " ('▁years', 49),\n",
       " ('.', 7),\n",
       " ('▁primary', 255),\n",
       " ('▁central', 401),\n",
       " ('▁nervous', 630),\n",
       " ('▁system', 310),\n",
       " ('▁malignancy', 271),\n",
       " ('.', 7),\n",
       " ('▁major', 245),\n",
       " ('▁surgery', 108),\n",
       " ('▁', 5),\n",
       " ('=', 40),\n",
       " ('▁', 5),\n",
       " ('28', 376),\n",
       " ('▁days', 81),\n",
       " ('▁before', 117),\n",
       " ('▁start', 417),\n",
       " ('▁of', 8),\n",
       " ('▁study', 26),\n",
       " ('▁treatment', 56),\n",
       " ('.', 7),\n",
       " ('▁any', 44),\n",
       " ('▁un', 495),\n",
       " ('resolved', 2272),\n",
       " ('▁', 5),\n",
       " ('toxicity', 940),\n",
       " ('▁of', 8),\n",
       " ('▁grade', 272),\n",
       " ('▁', 5),\n",
       " ('=', 40),\n",
       " ('▁', 5),\n",
       " ('2', 24),\n",
       " (',', 6),\n",
       " ('▁not', 60),\n",
       " ('▁otherwise', 1207),\n",
       " ('▁specified', 701),\n",
       " ('▁in', 21),\n",
       " ('▁other', 63),\n",
       " ('▁eligibility', 934),\n",
       " (',', 6),\n",
       " ('▁criteria', 96),\n",
       " (',', 6),\n",
       " ('▁from', 93),\n",
       " ('▁previous', 130),\n",
       " ('▁anticancer', 1331),\n",
       " ('▁treatment', 56),\n",
       " (',', 6),\n",
       " ('▁except', 430),\n",
       " ('▁for', 20),\n",
       " ('▁alopecia', 1609),\n",
       " ('▁and', 17),\n",
       " ('▁skin', 237),\n",
       " (',', 6),\n",
       " ('▁', 5),\n",
       " ('pigmentation', 5484),\n",
       " ('.', 7),\n",
       " ('▁uncontrolled', 198),\n",
       " ('▁intercurrent', 1702),\n",
       " ('▁illness', 243),\n",
       " ('▁requiring', 231),\n",
       " ('▁systemic', 153),\n",
       " ('▁treatment', 56),\n",
       " ('▁or', 10),\n",
       " ('▁solid', 881),\n",
       " ('▁organ', 423),\n",
       " (',', 6),\n",
       " ('▁transplant', 556),\n",
       " ('.', 7),\n",
       " ('▁known', 99),\n",
       " ('▁', 5),\n",
       " ('hypersensitivity', 264),\n",
       " ('▁to', 13),\n",
       " ('▁study', 26),\n",
       " ('▁treatment', 56),\n",
       " ('▁or', 10),\n",
       " ('▁any', 44),\n",
       " ('▁drugs', 158),\n",
       " ('▁similar', 1132),\n",
       " ('▁in', 21),\n",
       " ('▁structure', 1800),\n",
       " ('▁or', 10),\n",
       " ('▁class', 447),\n",
       " (',', 6),\n",
       " ('▁including', 141),\n",
       " ('▁severe', 105),\n",
       " ('▁', 5),\n",
       " ('hypersensitivity', 264),\n",
       " ('▁', 5),\n",
       " ('(', 12),\n",
       " ('=', 40),\n",
       " ('▁grade', 272),\n",
       " ('▁', 5),\n",
       " ('3', 28),\n",
       " (')', 11),\n",
       " ('▁to', 13),\n",
       " ('▁pembrolizumab', 3638),\n",
       " ('▁and', 17),\n",
       " ('/', 25),\n",
       " ('or', 87),\n",
       " ('▁any', 44),\n",
       " ('▁of', 8),\n",
       " ('▁its', 896),\n",
       " (',', 6),\n",
       " ('▁excipients', 852),\n",
       " ('.', 7),\n",
       " ('▁any', 44),\n",
       " ('▁', 5),\n",
       " ('toxicity', 940),\n",
       " ('▁', 5),\n",
       " ('(', 12),\n",
       " ('grade', 1143),\n",
       " ('▁', 5),\n",
       " ('3', 28),\n",
       " ('▁or', 10),\n",
       " ('▁', 5),\n",
       " ('4', 46),\n",
       " (')', 11),\n",
       " ('▁related', 445),\n",
       " ('▁to', 13),\n",
       " ('▁prior', 34),\n",
       " ('▁immunotherapy', 928),\n",
       " ('▁lead', 1315),\n",
       " ('ing', 88),\n",
       " ('▁to', 13),\n",
       " ('▁prior', 34),\n",
       " ('▁treatment', 56),\n",
       " (',', 6),\n",
       " ('▁discontinuation', 1280),\n",
       " ('.', 7),\n",
       " ('▁history', 50),\n",
       " ('▁of', 8),\n",
       " ('▁congestive', 516),\n",
       " ('▁heart', 143),\n",
       " ('▁failure', 171),\n",
       " ('▁new', 476),\n",
       " ('▁york', 801),\n",
       " ('▁heart', 143),\n",
       " ('▁association', 660),\n",
       " ('▁', 5),\n",
       " ('(', 12),\n",
       " ('nyha', 978),\n",
       " (')', 11),\n",
       " ('▁', 5),\n",
       " ('>', 55),\n",
       " ('i', 27),\n",
       " ('i', 27),\n",
       " ('.', 7),\n",
       " ('▁medical', 112),\n",
       " ('▁history', 50),\n",
       " ('▁of', 8),\n",
       " ('▁', 5),\n",
       " ('(', 12),\n",
       " ('non', 1222),\n",
       " ('-', 16),\n",
       " ('infectious', 2781),\n",
       " (')', 11),\n",
       " ('▁pneumoniti', 1590),\n",
       " ('s', 15),\n",
       " ('/', 25),\n",
       " ('interstitial', 6013),\n",
       " ('▁lung', 380),\n",
       " ('▁disease', 42),\n",
       " ('▁', 5),\n",
       " ('(', 12),\n",
       " ('ild', 3681),\n",
       " (')', 11),\n",
       " (',', 6),\n",
       " ('▁drug', 94),\n",
       " ('-', 16),\n",
       " ('induced', 986),\n",
       " ('▁', 5),\n",
       " ('ild', 3681),\n",
       " (',', 6),\n",
       " ('▁radiation', 393),\n",
       " ('▁pneumoniti', 1590),\n",
       " ('s', 15),\n",
       " ('▁which', 157),\n",
       " ('▁required', 306),\n",
       " ('▁steroid', 847),\n",
       " ('▁treatment', 56),\n",
       " (',', 6),\n",
       " ('▁or', 10),\n",
       " ('▁any', 44),\n",
       " (',', 6),\n",
       " ('▁evidence', 170),\n",
       " ('▁of', 8),\n",
       " ('▁clinically', 149),\n",
       " ('-', 16),\n",
       " ('active', 1329),\n",
       " ('▁pneumoniti', 1590),\n",
       " ('s', 15),\n",
       " ('/', 25),\n",
       " ('ild', 3681),\n",
       " ('.', 7),\n",
       " ('▁hiv', 278),\n",
       " ('-', 16),\n",
       " ('infection', 2111),\n",
       " ('▁with', 19),\n",
       " ('▁', 5),\n",
       " ('a', 14),\n",
       " ('▁history', 50),\n",
       " ('▁of', 8),\n",
       " ('▁kaposi', 5205),\n",
       " ('▁sarcoma', 2174),\n",
       " ('▁and', 17),\n",
       " ('/', 25),\n",
       " ('or', 87),\n",
       " ('▁multicentric', 9239),\n",
       " ('▁cast', 6099),\n",
       " ('l', 43),\n",
       " ('e', 22),\n",
       " ('man', 2194),\n",
       " ('▁disease', 42),\n",
       " ('.', 7),\n",
       " ('▁known', 99),\n",
       " ('▁psychiatric', 257),\n",
       " ('▁or', 10),\n",
       " ('▁substance', 540),\n",
       " ('▁abuse', 266),\n",
       " ('▁disorder', 147),\n",
       " ('▁that', 67),\n",
       " ('▁would', 210),\n",
       " ('▁interfere', 285),\n",
       " ('▁with', 19),\n",
       " ('▁the', 9),\n",
       " (',', 6),\n",
       " ('▁participant', 286),\n",
       " (\"'\", 140),\n",
       " ('s', 15),\n",
       " ('▁ability', 304),\n",
       " ('▁to', 13),\n",
       " ('▁cooperate', 1342),\n",
       " ('▁with', 19),\n",
       " ('▁the', 9),\n",
       " ('▁requirements', 379),\n",
       " ('▁of', 8),\n",
       " ('▁the', 9),\n",
       " ('▁study', 26),\n",
       " ('.', 7),\n",
       " ('▁history', 50),\n",
       " ('▁or', 10),\n",
       " ('▁current', 144),\n",
       " ('▁evidence', 170),\n",
       " ('▁of', 8),\n",
       " ('▁any', 44),\n",
       " ('▁condition', 160),\n",
       " (',', 6),\n",
       " ('▁therapy', 71),\n",
       " (',', 6),\n",
       " ('▁laboratory', 218),\n",
       " ('▁abnormality', 609),\n",
       " (',', 6),\n",
       " ('▁or', 10),\n",
       " (',', 6),\n",
       " ('▁other', 63),\n",
       " ('▁circumstance', 4481),\n",
       " ('▁that', 67),\n",
       " ('▁might', 666),\n",
       " ('▁confound', 1022),\n",
       " ('▁the', 9),\n",
       " ('▁results', 372),\n",
       " ('▁of', 8),\n",
       " ('▁the', 9),\n",
       " ('▁study', 26),\n",
       " ('▁or', 10),\n",
       " ('▁interfere', 285),\n",
       " ('▁with', 19),\n",
       " ('▁the', 9),\n",
       " (',', 6),\n",
       " ('▁participant', 286),\n",
       " (\"'\", 140),\n",
       " ('s', 15),\n",
       " ('▁participation', 151),\n",
       " ('▁for', 20),\n",
       " ('▁the', 9),\n",
       " ('▁full', 810),\n",
       " ('▁duration', 338),\n",
       " ('▁of', 8),\n",
       " ('▁the', 9),\n",
       " ('▁study', 26),\n",
       " (',', 6),\n",
       " ('▁such', 165),\n",
       " ('▁that', 67),\n",
       " ('▁', 5),\n",
       " ('i', 27),\n",
       " ('t', 35),\n",
       " ('▁is', 53),\n",
       " ('▁not', 60),\n",
       " ('▁in', 21),\n",
       " (',', 6),\n",
       " ('▁the', 9),\n",
       " ('▁best', 1646),\n",
       " ('▁interest', 2095),\n",
       " ('▁of', 8),\n",
       " ('▁the', 9),\n",
       " ('▁participant', 286),\n",
       " ('▁to', 13),\n",
       " ('▁participate', 195),\n",
       " (',', 6),\n",
       " ('▁in', 21),\n",
       " ('▁the', 9),\n",
       " ('▁opinion', 217),\n",
       " ('▁of', 8),\n",
       " ('▁the', 9),\n",
       " ('▁treating', 1038),\n",
       " (',', 6),\n",
       " ('▁investigator', 106),\n",
       " ('.', 7),\n",
       " ('▁any', 44),\n",
       " ('▁other', 63),\n",
       " ('▁history', 50),\n",
       " (',', 6),\n",
       " ('▁condition', 160),\n",
       " (',', 6),\n",
       " ('▁therapy', 71),\n",
       " (',', 6),\n",
       " ('▁or', 10),\n",
       " ('▁uncontrolled', 198),\n",
       " ('▁intercurrent', 1702),\n",
       " ('▁illness', 243),\n",
       " ('▁which', 157),\n",
       " (',', 6),\n",
       " ('▁could', 412),\n",
       " ('▁in', 21),\n",
       " ('▁the', 9),\n",
       " ('▁opinion', 217),\n",
       " ('▁of', 8),\n",
       " ('▁the', 9),\n",
       " ('▁investigator', 106),\n",
       " ('▁affect', 405),\n",
       " ('▁compliance', 533),\n",
       " ('▁with', 19),\n",
       " ('▁study', 26),\n",
       " ('▁requirements', 379),\n",
       " ('.', 7),\n",
       " ('▁new', 476),\n",
       " ('▁brain', 316),\n",
       " ('▁metastases', 383),\n",
       " ('▁', 5),\n",
       " ('o', 30),\n",
       " ('n', 33),\n",
       " ('▁screening', 73),\n",
       " ('▁brain', 316),\n",
       " ('▁mri', 448),\n",
       " ('/', 25),\n",
       " ('c', 45),\n",
       " ('t', 35),\n",
       " (';', 29),\n",
       " ('▁previously', 394),\n",
       " ('▁treated', 181),\n",
       " ('▁brain', 316),\n",
       " ('▁metastases', 383),\n",
       " (',', 6),\n",
       " ('▁that', 67),\n",
       " ('▁are', 59),\n",
       " ('▁progressive', 722),\n",
       " ('▁at', 32),\n",
       " ('▁screening', 73),\n",
       " ('▁or', 10),\n",
       " ('▁leptomeningeal', 1888),\n",
       " ('▁disease', 42),\n",
       " ('.', 7),\n",
       " ('▁prior', 34),\n",
       " ('▁therapy', 71),\n",
       " ('▁with', 19),\n",
       " ('▁', 5),\n",
       " ('a', 14),\n",
       " ('▁', 5),\n",
       " ('c', 45),\n",
       " ('-', 16),\n",
       " ('c', 45),\n",
       " ('▁', 5),\n",
       " ('m', 66),\n",
       " ('o', 30),\n",
       " ('t', 35),\n",
       " ('i', 27),\n",
       " ('f', 39),\n",
       " ('▁chemo', 2641),\n",
       " ('kin', 4636),\n",
       " ('e', 22),\n",
       " ('▁receptor', 838),\n",
       " ('▁', 5),\n",
       " ('8', 97),\n",
       " ('▁', 5),\n",
       " ('(', 12),\n",
       " ('c', 45),\n",
       " ('c', 45),\n",
       " ('r', 58),\n",
       " ('8', 97),\n",
       " (')', 11),\n",
       " ('▁', 5),\n",
       " ('deplet', 6533),\n",
       " ('ing', 88),\n",
       " ('▁antibody', 480),\n",
       " ('.', 7),\n",
       " ('▁prior', 34),\n",
       " ('▁allogeneic', 1373),\n",
       " ('▁tissue', 528),\n",
       " ('/', 25),\n",
       " ('solid', 6227),\n",
       " ('▁organ', 423),\n",
       " ('▁transplant', 556),\n",
       " ('.', 7),\n",
       " ('▁radiation', 393),\n",
       " ('▁therapy', 71),\n",
       " ('▁to', 13),\n",
       " ('▁the', 9),\n",
       " ('▁lung', 380),\n",
       " ('▁that', 67),\n",
       " ('▁is', 53),\n",
       " ('▁', 5),\n",
       " ('>', 55),\n",
       " ('▁', 5),\n",
       " ('30', 116),\n",
       " ('▁', 5),\n",
       " ('g', 48),\n",
       " ('y', 70),\n",
       " ('▁within', 41),\n",
       " ('▁', 5),\n",
       " ('6', 57),\n",
       " ('▁months', 65),\n",
       " ('▁before', 117),\n",
       " ('▁the', 9),\n",
       " ('▁start', 417),\n",
       " ('▁of', 8),\n",
       " (',', 6),\n",
       " ('▁study', 26),\n",
       " ('▁treatment', 56),\n",
       " ('.', 7),\n",
       " ('▁diagnosis', 131),\n",
       " ('▁of', 8),\n",
       " ('▁', 5),\n",
       " ('immunodeficiency', 429),\n",
       " ('▁or', 10),\n",
       " ('▁current', 144),\n",
       " ('▁chronic', 134),\n",
       " ('▁systemic', 153),\n",
       " ('▁steroid', 847),\n",
       " ('▁therapy', 71),\n",
       " ('▁', 5),\n",
       " ('(', 12),\n",
       " ('in', 214),\n",
       " ('▁dosing', 579),\n",
       " (',', 6),\n",
       " ('▁exceeding', 2044),\n",
       " ('▁', 5),\n",
       " ('10', 95),\n",
       " ('▁mg', 168),\n",
       " ('▁daily', 492),\n",
       " ('▁of', 8),\n",
       " ('▁prednisone', 927),\n",
       " ('▁equivalent', 557),\n",
       " (')', 11),\n",
       " ('.', 7),\n",
       " ('▁active', 100),\n",
       " ('▁autoimmune', 532),\n",
       " ('▁disease', 42),\n",
       " ('▁that', 67),\n",
       " ('▁has', 72),\n",
       " ('▁required', 306),\n",
       " ('▁systemic', 153),\n",
       " ('▁treatment', 56),\n",
       " ('▁in', 21),\n",
       " ('▁the', 9),\n",
       " ('▁past', 161),\n",
       " ('▁', 5),\n",
       " ('2', 24),\n",
       " ('▁years', 49),\n",
       " ('.', 7)]"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tokens = tokenizer.tokenize(texts[0])\n",
    "ids = tokenizer(texts[0])['input_ids'][1:-1]\n",
    "list(zip(tokens, ids))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### TODO\n",
    "\n",
    "- show examples of randomness in tokenization"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "[Table of content](#TOC)"
   ]
  }
 ],
 "metadata": {
  "colab": {
   "name": "Token Classification",
   "provenance": []
  },
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 1
}
